Which medications in the drug class Alpha2-adrenergic agonists are used in the treatment of Secondary Congenital Glaucoma?

Updated: Jul 27, 2020
  • Author: Inci Irak Dersu, MD, MPH; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print

Alpha2-adrenergic agonists

These agents decrease IOP.

Brimonidine (Alphagan, Alphagan-P 0.15% and 0.10 %)

Lowers IOP by decreasing aqueous production and increasing uveoscleral outflow. Should be avoided in children younger than 3 years.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!